IDEXX Laboratories, Inc. Stock Borsa Italiana
Stocks
1IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
17:13:50 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 461.75 EUR | -0.87% |
|
+2.31% | -19.86% |
| 09-30 | IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI | MT |
| 09-17 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike | MT |
| Market Cap | 40.79B 36.23B 33.88B 30.87B 58.12B 3,927B 58.92B 410B 159B 2,000B 153B 150B 6,424B | P/E 2026 * |
35.1x | P/E 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise Value | 41.16B 36.56B 34.19B 31.15B 58.65B 3,963B 59.46B 414B 160B 2,018B 155B 151B 6,482B | EV / Sales 2026 * |
8.71x | EV / Sales 2027 * | 7.92x |
| Free-Float |
72.37% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IDXX | Delayed | |
CBOE
| IDXX | Real-time | |
|
London S.E.
| 0J8P | Delayed | |
|
Tradegate
| IX1 | Real-time | |
|
Mexican S.E.
| IDXX * | End-of-day quote | |
|
Boerse Muenchen
| IX1 | Real-time | |
|
Deutsche Boerse AG
| IX1 | Delayed | |
|
Wiener Boerse
| IDXX | End-of-day quote | |
|
Börse Stuttgart
| IX1 | Delayed | |
|
Xetra
| IX1 | Delayed | |
|
Berne S.E.
| IX1 | End-of-day quote | |
|
Borsa Italiana
| 1IDXX | End-of-day quote |
Last Transcript: IDEXX Laboratories, Inc.
| 1 day | -0.98% | ||
| 1 week | +2.31% | ||
| Current month | +0.84% | ||
| 1 month | -0.91% | ||
| 3 months | -0.77% | ||
| 6 months | -4.33% | ||
| Current year | -19.86% |
| 1 week | 457.4 |  | 478.7 |
| 1 month | 382.7 | | 478.7 |
| Current year | 382.7 | | 629 |
| 1 year | 382.7 | | 664.6 |
| 3 years | 381.3 | | 664.6 |
| 5 years | 381.3 | | 664.6 |
| 10 years | 161.6 | | 664.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Erickson
CEO | Chief Executive Officer | 52 | 12/05/2026 |
Andrew Emerson
DFI | Director of Finance/CFO | 43 | 01/03/2025 |
Martin Smith
COO | Chief Operating Officer | 58 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 12/05/2026 | |
| Director/Board Member | 64 | 15/07/2013 | |
Daniel Junius
BRD | Director/Board Member | 73 | 11/03/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | +2.31% | - | - | 40.79B | |
| -0.47% | -5.29% | -27.87% | +0.21% | 167B | |
| +0.33% | -2.85% | -9.81% | +10.73% | 111B | |
| +0.56% | +0.22% | -25.50% | -0.32% | 105B | |
| +0.62% | +1.15% | -48.05% | -11.07% | 74.82B | |
| -1.88% | -1.02% | -1.55% | +69.64% | 59.11B | |
| -0.86% | +2.96% | +13.57% | +59.50% | 51.8B | |
| -0.46% | -3.79% | -7.69% | -31.39% | 48.5B | |
| +0.39% | -0.39% | -18.39% | +20.03% | 40.79B | |
| -0.72% | -1.32% | +28.66% | -9.59% | 32.54B | |
| Average | -0.41% | -0.16% | -10.74% | +11.97% | 76.68B | |
| Weighted average by Cap. | -0.31% | -0.91% | -16.80% | +9.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.19B 3.92B 3.57B 6.73B 455B 6.82B 47.45B 18.37B 232B 17.73B 17.35B 744B | 5.14B 4.57B 4.27B 3.89B 7.33B 495B 7.43B 51.66B 20B 252B 19.3B 18.88B 810B |
| Net income | 1.18B 1.05B 979M 892M 1.68B 114B 1.7B 11.85B 4.59B 57.81B 4.43B 4.33B 186B | 1.31B 1.17B 1.09B 995M 1.87B 127B 1.9B 13.21B 5.11B 64.46B 4.94B 4.83B 207B |
| Net Debt | 368M 327M 306M 279M 524M 35.43B 532M 3.7B 1.43B 18.04B 1.38B 1.35B 57.96B | -97.34M -86.46M -80.85M -73.68M -139M -9.37B -141M -978M -379M -4.77B -365M -358M -15.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | €465.80 | +1.84% | 0 |
| 01/10/26 | €462.80 | +0.19% | 5 |
| 30/09/26 | €461.90 | -0.84% | 0 |
| 29/09/26 | €465.80 | +1.84% | 0 |
| 28/09/26 | €457.40 | +0.70% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
- 1IDXX Stock
Select your edition
All financial news and data tailored to specific country editions
